Tier 2 — strong

Betaine-containing toothpaste relieves subjective symptoms of dry mouth

E Söderling, A Le Bell, V Kirstilä, J Tenovuo
Acta odontologica Scandinavica 1998 56(2):65-69

Bibliography

PubMed
PMID 9669455
DOI
10.1080/00016359850136003
Funding
Funding was not specified in the indexed record or accessible funding metadata.
Competing interests
A competing-interest declaration was not available in the indexed record or accessible disclosure metadata.

Study snapshot

DesignControlled crossover trial
ModelHuman participants
Sample13 people with chronic dry mouth
InterventionToothpaste with or without 4% betaine
Duration2 weeks per toothpaste
EndpointsDry-mouth symptoms; Oral mucosa; Microbiology

What the study showed, in plain terms

Published in 1998, this source examined betaine hcl and topical formulations. Design: Controlled crossover trial. Sample/model: 13 people with chronic dry mouth. The exposure or intervention was Toothpaste with or without 4% betaine. Follow-up or treatment period: 2 weeks per toothpaste.

Several subjective dry-mouth symptoms improved with betaine toothpaste, without clear changes in oral microbes or mucosal appearance.

Small local-use study with subjective outcomes; it does not test swallowed TMG capsules.

Continue with TMG Data Center

Continue with Betaine Anhydrous vs Betaine HCl: Which Form Is TMG?

Key findings

  • Several subjective dry-mouth symptoms improved with betaine toothpaste, without clear changes in oral microbes or mucosal appearance.
  • The recorded outcome domains were Dry-mouth symptoms; Oral mucosa; Microbiology.
  • The result applies to the tested exposure: Toothpaste with or without 4% betaine; 2 weeks per toothpaste.

What this study can and cannot tell us

  • Small local-use study with subjective outcomes; it does not test swallowed TMG capsules.
  • An individual controlled trial must be interpreted alongside its comparator, sample size, endpoint selection and independent replication. It does not validate a different commercial formulation or a general longevity claim.
  • Source basis: Indexed abstract and bibliographic data. Missing method details, funding information or participant denominators are not inferred.

Related papers in the corpus

Tier 4
Meal-Time Supplementation with Betaine HCl for Functional Hypochlorhydria: What is the Evidence?
Thomas G Guilliams et al. · Integrative medicine (Encinitas, Calif.) · 2020
Tier 2
Gastric reacidification with betaine HCl in healthy volunteers with rabeprazole-induced hypochlorhydria
Marc R Yago et al. · Molecular pharmaceutics · 2013
Tier 2
The use of betaine HCl to enhance dasatinib absorption in healthy volunteers with rabeprazole-induced hypochlorhydria
Marc R Yago et al. · The AAPS journal · 2014
Tier 2
Food, Acid Supplementation and Drug Absorption - a Complicated Gastric Mix: a Randomized Control Trial
Dalga D Surofchy et al. · Pharmaceutical research · 2019

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified

Dr. Khaled Mahmoud, MBBChCritical Care Medicine, Longevity Science & Editorial Direction Dr. Amr Yasser, PhDCardiometabolic, Musculoskeletal, Gut & Bioavailability Dr. Abdulla Mostafa, PhDCellular Senescence, Neurological, Mitochondrial & Brain-Ageing Biology